Increased glucocorticoid receptor-β expression, but not decreased histone deacetylase 2, in severe asthma [1]

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 3, 2006, Pages 703-705

  Bergeron, Celine ^a   Fukakusa, Motoroni ^a   Olivenstein, Ronald ^b   Lemiere, Catherine ^c   Shannon, Joanne ^a   Ernst, Pierre ^b   Martin, James G ^a,b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HISTONE DEACETYLASE 2;

ASTHMA; COMORBIDITY; DISEASE SEVERITY; EPITHELIUM CELL; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LETTER; MORBIDITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION;

ADULT; AGED; ASTHMA; DRUG RESISTANCE; FEMALE; HISTONE DEACETYLASES; HUMANS; MALE; MIDDLE AGED; RECEPTORS, GLUCOCORTICOID; REPRESSOR PROTEINS;

EID: 33644777427     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.12.1344     Document Type: Letter

References (10)

1. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
2. S.E. Wenzel, S.J. Szefler, D.Y. Leung, S.I. Sloan, M.D. Rex, and R.J. Martin Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids Am J Respir Crit Care Med 156 1997 737 743
3. C.M. Bamberger, A.M. Bamberger, M. de Castro, and G.P. Chrousos Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans J Clin Invest 95 1995 2435 2441
4. J.G. Matthews, K. Ito, P.J. Barnes, and I.M. Adcock Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients J Allergy Clin Immunol 113 2004 1100 1108
5. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986 Am Rev Respir Dis 136 1987 225 244
6. M. Fukakusa, C. Bergeron, M.K. Tulic, P.O. Fiset, O. Al Dewachi, and M. Laviolette Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa J Allergy Clin Immunol 115 2005 280 286
7. P. Christodoulopoulos, D.Y. Leung, M.W. Elliott, J.C. Hogg, S. Muro, and M. Toda Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma J Allergy Clin Immunol 106 2000 479 484
8. Q.A. Hamid, S.E. Wenzel, P.J. Hauk, A. Tsicopoulos, B. Wallaert, and J.J. Lafitte Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma Am J Respir Crit Care Med 159 1999 1600 1604
9. I. Strickland, K. Kisich, P.J. Hauk, A. Vottero, G.P. Chrousos, and D.J. Klemm High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids J Exp Med 193 2001 585 593
10. K. Ito, G. Caramori, S. Lim, T. Oates, K.F. Chung, and P.J. Barnes Expression and activity of histone deacetylases in human asthmatic airways Am J Respir Crit Care Med 166 2002 392 396